Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1908 1
1925 1
1926 1
1927 1
1928 1
1929 2
1932 1
1934 2
1938 1
1946 5
1947 4
1948 2
1949 4
1950 8
1951 9
1952 14
1953 3
1954 10
1955 4
1956 10
1957 5
1958 5
1959 11
1960 5
1961 4
1962 4
1963 8
1964 5
1965 7
1966 8
1967 8
1968 6
1969 11
1970 10
1971 9
1972 18
1973 15
1974 14
1975 23
1976 24
1977 20
1978 18
1979 16
1980 23
1981 16
1982 15
1983 21
1984 14
1985 13
1986 18
1987 35
1988 24
1989 30
1990 43
1991 38
1992 43
1993 46
1994 65
1995 50
1996 49
1997 56
1998 55
1999 35
2000 44
2001 63
2002 37
2003 49
2004 64
2005 61
2006 76
2007 68
2008 62
2009 82
2010 77
2011 68
2012 89
2013 73
2014 78
2015 120
2016 125
2017 99
2018 90
2019 60
2020 66
2021 63
2022 59
2023 78
2024 88
2025 87

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,806 results

Results by year

Filters applied: . Clear all
Page 1
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, Nerette S, Nguyen NV, Pham TH, Pierre S, Purfield AE, Samaneka W, Savic RM, Sanne I, Scott NA, Shenje J, Sizemore E, Vernon A, Waja Z, Weiner M, Swindells S, Chaisson RE; AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Dorman SE, et al. Among authors: phillips ppj. N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400. N Engl J Med. 2021. PMID: 33951360 Free PMC article. Clinical Trial.
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Abubakirov A, Baudin E, Berikova E, Berry C, Bonnet M, Cellamare M, Chavan V, Cox V, Dakenova Z, de Jong BC, Ferlazzo G, Karabayev A, Kirakosyan O, Kiria N, Kunda M, Lachenal N, Lecca L, McIlleron H, Motta I, Toscano SM, Mushtaque H, Nahid P, Oyewusi L, Panda S, Patil S, Phillips PPJ, Ruiz J, Salahuddin N, Garavito ES, Seung KJ, Ticona E, Trippa L, Vasquez DEV, Wasserman S, Rich ML, Varaine F, Mitnick CD; endTB Clinical Trial Team. Guglielmetti L, et al. Among authors: phillips ppj. N Engl J Med. 2025 Jan 30;392(5):468-482. doi: 10.1056/NEJMoa2400327. N Engl J Med. 2025. PMID: 39879593 Free PMC article. Clinical Trial.
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.
Shimizu T, Sands J, Yoh K, Spira A, Garon EB, Kitazono S, Johnson ML, Meric-Bernstam F, Tolcher AW, Yamamoto N, Greenberg J, Kawasaki Y, Zebger-Gong H, Kobayashi F, Phillips P, Lisberg AE, Heist RS. Shimizu T, et al. Among authors: phillips p. J Clin Oncol. 2023 Oct 10;41(29):4678-4687. doi: 10.1200/JCO.23.00059. Epub 2023 Jun 16. J Clin Oncol. 2023. PMID: 37327461 Free PMC article. Clinical Trial.
REPLY.
Chauhan MZ, Elhusseiny AM, Phillips PH. Chauhan MZ, et al. Among authors: phillips ph. Ophthalmology. 2023 Nov;130(11):e39-e40. doi: 10.1016/j.ophtha.2023.07.013. Epub 2023 Aug 17. Ophthalmology. 2023. PMID: 37589635 No abstract available.
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Chang VK, Imperial MZ, Phillips PPJ, Velásquez GE, Nahid P, Vernon A, Kurbatova EV, Swindells S, Chaisson RE, Dorman SE, Johnson JL, Weiner M, Jindani A, Harrison T, Sizemore EE, Whitworth W, Carr W, Bryant KE, Burton D, Dooley KE, Engle M, Nsubuga P, Diacon AH, Nhung NV, Dawson R, Savic RM; AIDS Clinical Trial Group; Tuberculosis Trials Consortium. Chang VK, et al. Among authors: phillips ppj. Nat Commun. 2024 Oct 30;15(1):9400. doi: 10.1038/s41467-024-53273-7. Nat Commun. 2024. PMID: 39477924 Free PMC article. Clinical Trial.
Stranger than metals.
Phillips PW, Hussey NE, Abbamonte P. Phillips PW, et al. Science. 2022 Jul 8;377(6602):eabh4273. doi: 10.1126/science.abh4273. Epub 2022 Jul 8. Science. 2022. PMID: 35857547 Review.
Food intolerances.
Day M, Kuzin J, Spencer M, Hilliard T, Phillips P, Moore A. Day M, et al. Among authors: phillips p. Nursing. 2024 Feb 1;54(2):27-31. doi: 10.1097/01.NURSE.0000997984.19998.cf. Nursing. 2024. PMID: 38271126 Review.
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Pettit AC, Phillips PPJ, Kurbatova E, Vernon A, Nahid P, Dawson R, Dooley KE, Sanne I, Waja Z, Mohapi L, Podany AT, Samaneka W, Savic RM, Johnson JL, Muzanyi G, Lalloo UG, Bryant K, Sizemore E, Scott N, Dorman SE, Chaisson RE, Swindells S; Tuberculosis Trials Consortium (TBTC) Study 31/AIDS Clinical Trials Group (ACTG) A5349 study team. Pettit AC, et al. Among authors: phillips ppj. Clin Infect Dis. 2023 Feb 8;76(3):e580-e589. doi: 10.1093/cid/ciac707. Clin Infect Dis. 2023. PMID: 36041016 Free PMC article. Clinical Trial.
Reply.
Kilgore DA, Sallam AB, Phillips PH. Kilgore DA, et al. Among authors: phillips ph. J AAPOS. 2022 Feb;26(1):51. doi: 10.1016/j.jaapos.2021.12.001. Epub 2022 Jan 22. J AAPOS. 2022. PMID: 35077817 No abstract available.
2,806 results